NIH Director Francis Collins has approved another human embryonic stem cell line for federal taxpayer funding. The line, HUES PGD 14, was added to the NIH registry today, bringing the total number of approved hESC lines to 136. The line was created by Harvard University from a female embryo, and according to the information provided on the NIH website: "The embryo from which this hESC line was derived was determined through preimplantation genetic diagnosis to be affected with Spinal Muscular Atrophy." This highlights the point made by Dr. James Sherley and Dr. Theresa Deisher in the ongoing Sherley et al. v. Sebelius et al. case, that there is a continued demand for more embryo destruction and more hESC lines, and the current NIH guidelines continue to provide an incentive for more human embryo destruction.

Meanwhile, adult stem cells remain the gold standard for patient treatments. You can see some examples at Stem Cell Research Facts.